PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 29, 2026Hypertension Research0 citationsOpen Access

A novel mouse model of adenine-supplemented high-fat diet induced cardiovascular-kidney-metabolic syndrome

View Full Paper
HOHiroe OnoYOYoichiro OtakiTWT Watanabe

Key Points

  • This research aims to establish a mouse model for studying cardiovascular-kidney-metabolic syndrome induced by a specific diet.
  • Feed normal chow diet (NCD), adenine-supplemented diet (AD), high-fat diet (HFD), and adenine-supplemented high-fat diet (AHFD) to mice for up to 16 weeks.
  • Utilize two different mouse strains: 129×1/Sv and C57BL/6 N mice for dietary intervention.
  • Analyze metabolic parameters, blood pressure, organ weights, histology, and RNA sequencing data.
  • 0.15% AHFD induced hypercholesterolemia, elevated blood pressure, kidney atrophy with fibrosis, and cardiac hypertrophy.
  • 0.2% AHFD caused body weight loss and severe kidney dysfunction without functional impairment.
  • C57BL/6 N mice showed metabolic abnormality and cardiac hypertrophy with diastolic dysfunction.

Abstract

Abstract Cardiovascular-kidney-metabolic (CKM) syndrome, a recently proposed concept focusing on the interrelationship among cardiovascular system, chronic kidney disease, and metabolic risk factors, is associated with high morbidity and mortality. The mechanism of CKM syndrome has not yet been fully examined due to the lack of an animal model. Here, we investigated whether an adenine-supplemented high-fat diet (AHFD) can induce CKM syndrome in mice. We fed normal chow diet (NCD), adenine-supplemented diet (AD), high-fat diet (HFD), and 0.15% AHFD to 129×1/Sv mice for 16 weeks and 0.2%AHFD to 129×1/Sv for 6 weeks. Also, C57BL/6 N mice were fed with 0.15%AHFD for 16 weeks. Metabolic parameters, blood pressure, organ weights, histology, and RNA sequencing were analyzed. The 0.15%AHFD group exhibited hypercholesterolemia, elevated blood pressure, kidney atrophy with fibrosis, and cardiac hypertrophy with interstitial fibrosis. Both kidney and cardiac RNA sequencing in the 0.15%AHFD group revealed upregulation of inflammatory and immune-related gene sets, whereas genes involved in cardiac contraction were downregulated. In contrast, 0.2%AHFD induced body weight loss, severe kidney dysfunction, and cardiac atrophy without functional impairment in 129×1/Sv mice. Of note, the C57BL/6 N mice exhibited metabolic abnormality and cardiac hypertrophy with diastolic dysfunction after 0.15%AHFD feeding despite mild renal dysfunction. We report a novel mouse model of CKM syndrome with dietary intervention, which exhibits fibrosis and myocardial hypertrophy in the heart. This model could be a valuable tool for analyzing the mechanism of CKM syndrome and assessing therapeutic options.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ono et al. (2026) studied this question.

synapsesocial.com/papers/69f154e0879cb923c494514dhttps://doi.org/10.1038/s41440-026-02645-1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1BS24 Establishing a clinically relevant progressive model of ckd-associated cardiomyopathy in mice for insights into early-stage pathogenesis2024
  2. 2BS47 Inflammatory response in a clinically relevant progressive model of chronic kidney disease-associated cardiomyopathy2025
  3. 3A novel model of cardiovascular–kidney–metabolic syndrome combining unilateral nephrectomy and high-salt–sugar–fat diet in mice2024 · 17 citations
  4. 4Construction of Chronic Kidney Disease Mouse Model Induced by Diets With Different Adenine Content2026
  5. 5Identifying biochemical changes in the kidney using proton nuclear magnetic resonance in an adenine diet chronic kidney disease mouse model2024 · 1 citations